Evidence map›Paper›PMID 42622442›Full record

ArticleScience progress

Staged matrix and micrografting reconstruction for no-option CLTI: A case report.

Dimitrios Miserlis, Lucas Ferrer, Reza M Mizani, Mark G Davies, Panagiotis Koutakis

Abstract readCase Reports
In one paragraph

Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dimitrios MiserlisVascular and Endovascular Surgery, Faculty, University of Texas at San Antonio, San Antonio, TX, USA.
Lucas FerrerCardiovascular Associates of West Texas, San Angelo, TX, USA.
Reza M MizaniSouth Texas Renal Group, San Antonio, TX, USA.
Mark G DaviesVascular and Endovascular Surgery, Ascension Health Care, Waco, TX, USA.
Panagiotis KoutakisCellular and Integrative Physiology, University of Nebraska at Medical Center, Omaha, NE, USA.ORCID 0000-0002-8352-5667

Funding

The Role of microRNA-210 in regulating oxidative stress in patients with peripheral artery diseaseR01AG064420 · NIA · UNIVERSITY OF WEST FLORIDA · PI KOUTAKIS, PANAGIOTIS · 2019 to 2023
$3.3M
NIA NIH HHS R01 AG064420
6 · The paper itself

Abstract

Venous arterialization has emerged as a limb-salvage option for selected patients with no-option chronic limb-threatening ischemia, particularly those with type 2 diabetes, extensive pedal occlusive disease, and small artery disease (distal tibial and inframalleolar disease) in whom conventional bypass or endovascular revascularization is not an option. We present a case of a man in his late 70s with diabetes and severe distal occlusive disease who underwent endovascular venous arterialization for a threatened limb with gangrene, followed by staged wound reconstruction after open transmetatarsal amputation. Reconstruction was performed in a stepwise manner with serial debridement and wound-bed preparation, application of an Integra dermal regeneration template to augment granulation tissue formation, and subsequent Meek fractional skin grafting for definitive coverage. The wound healed over approximately 7 months, and the patient regained the ability to ambulate. This case highlights the concept that venous arterialization should be viewed not as an isolated revascularization maneuver, but as the perfusion-enabling stage of a broader reconstructive pathway in no-option limb salvage.

Indexed as

Limb SalvagePlastic Surgery ProceduresSkin TransplantationAgedAmputation, SurgicalCollagenDiabetes Mellitus, Type 2HumansMaleCollagenchronic limb-threatening ischemiaintegralimb salvagemeek graftingsmall artery diseasetransmetatarsal amputationvenous arterialization

Identifiers

PMID42622442
PMCPMC13494304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.